Molecular Data Inc. (MKDTY)
OTCMKTS: MKDTY · Delayed Price · USD
0.0005
+0.0001 (25.00%)
Apr 15, 2024, 10:36 AM EDT - Market closed

Molecular Data Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Year 20202019201820172016
Revenue
7,59613,2469,0534,2023,206
Revenue Growth (YoY)
-42.65%46.31%115.46%31.06%-
Cost of Revenue
7,60713,1438,9734,1523,180
Gross Profit
-10.2103.0180.1750.2326.12
Selling, General & Admin
277.42213.33277.17106.68100.96
Research & Development
35.2245.0436.8918.6120.07
Other Operating Expenses
11.893.313.240.751.33
Operating Expenses
321.36292.99315.96139.97131.89
Operating Income
-331.56-189.97-235.79-91.18-105.77
Interest Expense
10.734.3719.0516.838.44
Other Expense / Income
-16.7-3.5-22.49-17.78-10.04
Pretax Income
-325.58-190.85-254.64-107.81-113.94
Income Tax
2.460.4322.2817.589.77
Net Income
-328.04-191.28-254.64-107.81-113.94
Shares Outstanding (Basic)
87888
Shares Outstanding (Diluted)
87888
Shares Change
21.06%-10.00%---
EPS (Basic)
-39.25-27.71-33.20-14.06-14.86
EPS (Diluted)
-39.25-27.71-33.20-14.06-14.86
Free Cash Flow
-234.16-97.64-136.88-188.64-148.24
Free Cash Flow Per Share
-28.02-14.15-17.85-24.60-19.33
Gross Margin
-0.13%0.78%0.89%1.20%0.81%
Operating Margin
-4.36%-1.43%-2.60%-2.17%-3.30%
Profit Margin
-4.32%-1.44%-2.81%-2.57%-3.55%
Free Cash Flow Margin
-3.08%-0.74%-1.51%-4.49%-4.62%
EBITDA
-318.59-186.66-230.12-87.49-103.47
EBITDA Margin
-4.19%-1.41%-2.54%-2.08%-3.23%
Depreciation & Amortization
1.723.052.441.490.98
EBIT
-320.31-189.71-232.56-88.98-104.44
EBIT Margin
-4.22%-1.43%-2.57%-2.12%-3.26%
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.